Investors
To Onyx's knowledge, all press releases, scientific papers, and abstracts and the information contained within them were timely and accurate when issued. The continued accuracy of this material beyond the date of issuance and posting on the website is not assured. Onyx has no intention of updating this information, and specifically disclaims any duty to do so. These documents may contain forward-looking statements. Actual results could vary dramatically as a result of known and unknown risks and uncertainties. Please see Terms of Use for this website.
Corporate Factsheet
Corporate Presentation
Stock Quote
(update every 15 minutes)
As of: 4:00pm - 4/15/2011
| Symbol | ONXX |
| Last | 34.74 0.00 |
| Open | N/A |
| High | N/A |
| Low | N/A |
| Volume | 600 |
Investor Relations Contacts
Julie Wood
(650) 266-2505
Traci McCarty
(650) 266-2398
Onyx Pharmaceuticals, Inc.
249 E. Grand Ave.
South San Francisco, CA 94080
Latest News